Airna will use the Series B round to launch a Phase 1/2 trial of its lead program for alpha-1 antitrypsin deficiency, a ...

AIRNA, a transatlantic RNA editing biotech, is prepping to launch its lead asset into clinical trials with fuel from a $155 ...

Colorectal cancer is a serious but preventable disease if detected early. Advances in diagnostics, such as biomarker analysis ...

Hyderabad: The Nizam’s Institute of Medical Sciences (NIMS), in the city will soon become the second hospital in the ...

A collaborative effort between The Wistar Institute, University of Pennsylvania, and INOVIO Pharmaceuticals has led to an ...

Verified Market Research®, a leading provider of business intelligence and market analysis is thrilled to announce the ...

BOSTON & MONTREAL, April 01, 2025--enGene Holdings Inc. (Nasdaq: ENGN or "enGene" or the "Company"), a clinical-stage, ...

The layoffs will take place throughout 2025 and will mostly affect Tenaya’s research and manufacturing operations. The ...

Biology — the science of life, living things and the processes that keep us all running — links up in essential ways with ...

Xun Jia, Rajat Mittal, Mihaela Pertea, and Sri Sarma honored for outstanding contributions to engineering and medicine ...

TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 registration-stage immune-oncology company ...

Singapore researchers are using Google DeepMind’s AlphaFold to understand the intricate protein interactions at play in ...